Brussels [Belgium]/New Delhi [India], November 4 (ANI/NewsVoir): At a time when votes from the US elections are still being counted, a group of 160 eminent global public lawyers have got together to reinforce the primacy of international law in safeguarding sovereign electoral processes f
Washington [US], October 27 (ANI): A new paper in Behavioral Ecology, published by Oxford University Press, finds that wild vampire bats, which are sick spend less time near others of their community, thereby slowing the spread of disease.
New Delhi [India], October 27 (ANI): Achieving world-class education in a world-renowned university is every scholar's dream but is often marred by the cost of living and exorbitant tuition fees.
London [UK], October 24 (ANI): The clinical trials for the AstraZeneca Oxford coronavirus vaccine -- AZD1222 -- have resumed in the United States after approval by the Food and Drug Administration (FDA), the company said on Friday (local time).
Brasilia [Brazil], October 22 (ANI): A volunteer in Brazil's clinical trial of COVID-19 vaccine being developed by AstraZeneca and Oxford University has died, the Brazilian health agency Anvisa announced on Wednesday while adding that the trial will continue.
Noida (Uttar Pradesh)[India], Oct 8 (ANI/NewsVoir): As part of their endeavour to support students and their learning, Prometheus School, Noida has signed a Memorandum of Understanding (MOU) with Gower College, Swansea, United Kingdom.
Pune (Maharashtra) [India], September 19 (ANI): Serum Institute of India (SII) is all set to begin phase three trials of the Covishield Vaccine developed by AstraZeneca and Oxford University at Sassoon General Hospital in Pune, the hospital administration said on Saturday.
New Delhi [India], September 16 (ANI): The Drugs Controller General of India (DCGI) has allowed Serum Institute of India (SII) to restart its phase two and three clinical trials for COVID-19 vaccine after the pharma major submitted the recommendations of the Data Safety Monitoring Board (DSM
New Delhi [India], September 12 (ANI): Hours after clinical trials for AstraZeneca and Oxford University coronavirus vaccine resumed on Saturday in the UK, pharma major Serum Institute of India (SII) said it will resume the trials in India once Drugs Controller General of India (DCGI) gives
London [UK], September 12 (ANI): The third phase of AstraZeneca's coronavirus vaccine trial has resumed in the UK, days after it was halted over safety concerns.
New Delhi [India], September 9 (ANI): After AstraZeneca suspended the trials of COVID-19 vaccine in the UK, Indian pharmaceutical giant Serum Institue of India (SII) on Wednesday clarified that testing of the possible vaccine candidate in India is ongoing and has not faced any issue so far.
London [UK], September 9 (ANI): UK-based biopharma giant AstraZeneca has said that the phase 3 testing of its COVID-19 vaccine being developed with Oxford University has been put on hold, due to a suspected serious adverse reaction in a participant in the United Kingdom.